British Journal of Clinical Pharmacology logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 56, Number 3, September 2003
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Free Content Features of this month's Journal
pp. 247-248(2)
Author: Aronson J.K.

Free Content The clinical pharmacology of ageing
pp. 249-253(5)
Author: Swift C.G.

Free Content The cardiovascular system
pp. 254-260(7)
Authors: Moore A.; Mangoni A.A.; Lyons D.; Jackson S.H.D.

Free Content Clinical pharmacology of old age syndromes
pp. 261-272(12)
Authors: Broadhurst C.; Wilson K.C.M.; Kinirons M.T.; Wagg A.; Dhesi J.K.

Free Content Diagnostic methods for Helicobacter pylori detection and eradication
pp. 273-283(11)
Authors: Goddard A.F.; Logan R.P.H.

Free Content Determining small bowel integrity following drug treatment
pp. 284-291(8)
Authors: Smale S.; Bjarnason I.

Free Content Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men
pp. 297-304(8)
Authors: Olubodun J.O.; Ochs H.R.; von Moltke L.L.; Roubenoff R.; Hesse L.M.; Harmatz J.S.; Shader R.I.; Greenblatt D.J.

Free Content CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
pp. 305-314(10)
Authors: Bidstrup T.B.; Bjørnsdottir I.; Sidelmann U.G.; Thomsen M.S.; Hansen K.T.

Free Content Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6
pp. 315-320(6)
Authors: Ohnuma T.; Shibata N.; Matsubara Y.; Arai H.

Free Content Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans
pp. 321-326(6)
Authors: Graff J.; Klinkhardt U.; Westrup D.; Kirchmaier C.M.; Breddin H.K.; Harder S.

Free Content Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids
pp. 327-330(4)
Authors: Hesselink D.A.; Ngyuen H.; Wabbijn M.; Gregoor P.J.H.S.; Steyerberg E.W.; van Riemsdijk I.C.; Weimar W.; van Gelder T.

Free Content Allele and genotype frequency of CYP2C19 in a Tamilian population
pp. 331-333(3)
Authors: Adithan C.; Gerard N.; Vasu S.; Rosemary J.; Shashindran C.H.; Krishnamoorthy R.

Free Content Interferon-bgr treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
pp. 337-340(4)
Authors: Hellman K.; Roos E.; Österlund A.; Wahlberg A.; Gustafsson L.L.; Bertilsson L.; Fredrikson S.

Free Content Identification of a novel splice-site mutation in the CYP1A2 gene
pp. 341-344(4)
Authors: Allorge D.; Chevalier D.; Lo-Guidice J-M.; Cauffiez C.; Suard F.; Baumann P.; Eap C.B.; Broly F.

Free Content The Forensic Pharmacology of Drugs of Abuse
pp. 345-346(2)
Author: Flanagan R.J.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A